These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 14517262)

  • 21. Prions of yeast as heritable amyloidoses.
    Wickner RB; Taylor KL; Edskes HK; Maddelein ML; Moriyama H; Roberts BT
    J Struct Biol; 2000 Jun; 130(2-3):310-22. PubMed ID: 10940235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular chaperone Hsp104 can promote yeast prion generation.
    Kryndushkin DS; Engel A; Edskes H; Wickner RB
    Genetics; 2011 Jun; 188(2):339-48. PubMed ID: 21467567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The yeast prion protein Ure2 shows glutathione peroxidase activity in both native and fibrillar forms.
    Bai M; Zhou JM; Perrett S
    J Biol Chem; 2004 Nov; 279(48):50025-30. PubMed ID: 15371425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Curing of yeast [URE3] prion by the Hsp40 cochaperone Ydj1p is mediated by Hsp70.
    Sharma D; Stanley RF; Masison DC
    Genetics; 2009 Jan; 181(1):129-37. PubMed ID: 19015537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Equilibrium folding properties of the yeast prion protein determinant Ure2.
    Perrett S; Freeman SJ; Butler PJ; Fersht AR
    J Mol Biol; 1999 Jul; 290(1):331-45. PubMed ID: 10388576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prion variants and species barriers among Saccharomyces Ure2 proteins.
    Edskes HK; McCann LM; Hebert AM; Wickner RB
    Genetics; 2009 Mar; 181(3):1159-67. PubMed ID: 19124570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The yeast prion protein Ure2: insights into the mechanism of amyloid formation.
    Chen LJ; Sawyer EB; Perrett S
    Biochem Soc Trans; 2011 Oct; 39(5):1359-64. PubMed ID: 21936815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Folding of the yeast prion protein Ure2: kinetic evidence for folding and unfolding intermediates.
    Galani D; Fersht AR; Perrett S
    J Mol Biol; 2002 Jan; 315(2):213-27. PubMed ID: 11779240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydrogen/deuterium exchange mass spectrometric analysis of conformational changes accompanying the assembly of the yeast prion Ure2p into protein fibrils.
    Redeker V; Halgand F; Le Caer JP; Bousset L; Laprévote O; Melki R
    J Mol Biol; 2007 Jun; 369(4):1113-25. PubMed ID: 17482207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is the prion domain of soluble Ure2p unstructured?
    Pierce MM; Baxa U; Steven AC; Bax A; Wickner RB
    Biochemistry; 2005 Jan; 44(1):321-8. PubMed ID: 15628874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ure2p function is enhanced by its prion domain in Saccharomyces cerevisiae.
    Shewmaker F; Mull L; Nakayashiki T; Masison DC; Wickner RB
    Genetics; 2007 Jul; 176(3):1557-65. PubMed ID: 17507672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural characterization of the fibrillar form of the yeast Saccharomyces cerevisiae prion Ure2p.
    Bousset L; Redeker V; Decottignies P; Dubois S; Le Maréchal P; Melki R
    Biochemistry; 2004 May; 43(17):5022-32. PubMed ID: 15109261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of inactivation on prion conversion of the Saccharomyces cerevisiae Ure2 protein.
    Baxa U; Speransky V; Steven AC; Wickner RB
    Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5253-60. PubMed ID: 11959975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Flexibility of the Ure2 prion domain is important for amyloid fibril formation.
    Yu Y; Wang HY; Bai M; Perrett S
    Biochem J; 2011 Feb; 434(1):143-51. PubMed ID: 21091436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutations Outside the Ure2 Amyloid-Forming Region Disrupt [URE3] Prion Propagation and Alter Interactions with Protein Quality Control Factors.
    Kumar S; Dine EA; Paddock E; Steinberg DN; Greene LE; Masison DC
    Mol Cell Biol; 2020 Oct; 40(21):. PubMed ID: 32868289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary sequence independence for prion formation.
    Ross ED; Edskes HK; Terry MJ; Wickner RB
    Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12825-30. PubMed ID: 16123127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prion-inducing domain of yeast Ure2p and protease resistance of Ure2p in prion-containing cells.
    Masison DC; Wickner RB
    Science; 1995 Oct; 270(5233):93-5. PubMed ID: 7569955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Real-time imaging of yeast cells reveals several distinct mechanisms of curing of the [URE3] prion.
    Zhao X; Lanz J; Steinberg D; Pease T; Ahearn JM; Bezsonov EE; Staguhn ED; Eisenberg E; Masison DC; Greene LE
    J Biol Chem; 2018 Mar; 293(9):3104-3117. PubMed ID: 29330300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Yeast prions: could they be exaptations? The URE2/[URE3] system in Kluyveromyces lactis.
    Safadi RA; Talarek N; Jacques N; Aigle M
    FEMS Yeast Res; 2011 Feb; 11(1):151-3. PubMed ID: 21235712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Innate immunity to yeast prions: Btn2p and Cur1p curing of the [URE3] prion is prevented by 60S ribosomal protein deficiency or ubiquitin/proteasome system overactivity.
    Bezsonov EE; Edskes HK; Wickner RB
    Genetics; 2021 Apr; 217(4):. PubMed ID: 33857305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.